Clinical Trials for AVM Biotechnology

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: AVM Biotechnology

Clinical Trials (2)

NCT04366115
Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS
PHASE1Not yet recruiting
16 participants
Started: Dec 1, 2026 · Completed: Mar 1, 2032
3 conditions2 sponsors0 locations
NCT04329728
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
PHASE1/PHASE2Recruiting
144 participants
Started: Nov 6, 2020 · Completed: Dec 1, 2026
1 condition2 sponsors11 locations